Literature DB >> 9160132

Ischemic time and free flap success.

A Gürlek1, S S Kroll, M A Schusterman.   

Abstract

Ischemic time (the time between the interruption and reestablishment of blood supply) was reviewed for 700 free flaps used for breast or head and neck reconstruction. Flaps that failed had a mean ischemic time of 111.64 minutes, while flaps that survived had a mean ischemic time of 91.25 minutes. The difference was not statistically significant (p = 0.189). The patients were then divided into two groups: those with flap ischemic times of 100 minutes or longer and those with flap ischemic times less than 100 minutes. We found that flap survival was similar in the two groups. Flap survival was also similar when 75 minutes and 120 minutes were used to segregate the longer and shorter ischemic time groups. When 180 minutes was used to segregate the groups, there was a slight trend toward more flap loss in the group with longer ischemic time, but the difference was not significant. We conclude that ischemic time is irrelevant to flap survival, provided that ischemia is not prolonged past 3 hours or to the point where the no-reflow phenomenon occurs.

Entities:  

Mesh:

Year:  1997        PMID: 9160132     DOI: 10.1097/00000637-199705000-00010

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  2 in total

1.  Abdominal aorta as a recipient artery: Using a free latissimus dorsi myocutaneous flap to close hip and pelvic defects.

Authors:  Gerrit Grieb; Ziyad Alharbi; David Simons; Savas Tsolakidis; Jan-Philipp Stromps; Andrzej Piatkowski; Paul Fuchs; Norbert Pallua
Journal:  Int J Surg Case Rep       Date:  2012-10-03

2.  Free Myocutaneous Flap Assessment in a Rat Model: Verification of a Wireless Bioelectrical Impedance Assessment (BIA) System for Vascular Compromise Following Microsurgery.

Authors:  Yao-Kuang Huang; Min Yi Wong; Chi-Rung Wu; Yung-Ze Cheng; Bor-Shyh Lin
Journal:  J Pers Med       Date:  2021-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.